Most Recent
Full Court hears government’s $325M fight with Sanofi over ban on Plavix generic
Acting Justice Arthur Emmett 2021-02-16 4:13 pm By Miklos Bolza

Pharmaceutical companies Sanofi and Bristol-Myers Squibb are liable for losses to the federal government for excess subsidies it allegedly paid for the blood-thinner Plavix after an unjustified court injunction prevented the release of a generic version of the top-selling drug, an appeals court has heard.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Government loses case claiming $325M over generic Plavix delay
Acting Justice Arthur Emmett 2020-04-28 6:05 pm By Miklos Bolza

A court has dismissed a claim by the Australian Government for $325 million against pharmaceutical companies Sanofi and Bristol-Myers Squibb allegedly owed for excess subsidies it paid for blood-thinner Plavix as a result of an interlocutory injunction blocking a generic version of the blockbuster drug.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?